| Objective: To investigate the clinical efficacy of dual task training in patients with mild cognitive impairment in Parkinson’s disease (PD-MCI). Method: A total of 40 cases of PD-MCI were selected and randomly divided into two groups: the control group (20 cases) and the experimental group (20 cases). Both groups received health education. The control group was given exercise training, and the treatment group received dual task training, additionally. Montreal Cognitive Assessment (MoCA), modified falls efficacy scale (MFES) and timed up and go test (TUG) under single task and dual task were applied to evaluate the cognitive function, walking function and falls efficacy with PD-MCI before treatment and 12 weeks after treatment. Results: After 12 weeks of treatment, the MoCA scores in the control group were not statistically different from those before training (P>0.05), and those in the experimental group were significantly higher than those before training (P<0.05). After treatment, the MFES scores in the two groups were significantly higher than those before training (P<0.05), and the MoCA score and MFES score in the experimental group were significantly higher than those in the control group (P<0.05). After 12 weeks of treatment, the single-task and dual-task TUG score in the two groups was significantly lower than that before training (P<0.05), and the single-task and dual-task TUG score in the experimental group were significantly lower than that in the control group (P<0.05). Conclusion: Dual task training can improve the cognitive function of early PD-MCI, improve walking function and balance ability, and enhance the patient’s confidence that they will not fall during activities, thereby reducing their risk of falling. |
